10月9日，四川双马涨5.09%，截至发稿，报22.51元/股，成交2.06亿元，换手率1.24%，总市值171.85亿 元。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 责任编辑：小浪快报 广发中证全指建筑材料指数A（004856）基金经理为陆志明。 截至发稿，陆志明累计任职时间14年133天，现任基金资产总规模246.29亿元，任职期间最佳基金回报 119.61%， 任职期间最差基金回报-63.28%。 资料显示，四川和谐双马股份有限公司位于四川省成都市锦江区红星路三段一号成都国际金融中心1号 写字楼26楼2号，成立日期1998年10月20日，上市日期1999年8月24日，公司主营业务涉及建材生产业 务、私募股权基金投资管理业务。主营业务收入构成为：私募股权投资基金管理33.36%，水泥 32.46%，生物医药23.08%，骨料11.10%。 从基金十大重仓股角度 数据显示，广发基金旗下1只基金重仓四川双马。广发中证全指建筑材料指数A（004856）二季度持有 股 ...

Group 1 - The article provides an overview of the performance of various funds, highlighting the top and bottom performers based on net asset value updates as of July 21, 2025 [3][4]. - The top 10 funds with the highest net value growth include several ETFs focused on construction materials, indicating a strong performance in this sector [3]. - The bottom 10 funds, such as the Morgan Stanley Hong Kong-Shanghai Select Mixed Fund C, show a decline in net value, suggesting challenges in their respective strategies [4]. Group 2 - The Shanghai Composite Index experienced a rebound, with a trading volume of 1.72 trillion, and a significant number of stocks advancing compared to those declining [6]. - The construction materials and engineering machinery sectors led the market with gains exceeding 4%, reflecting positive sentiment in these industries [6]. - The fund with the fastest net value growth is the Fortune China Securities All Index Construction Materials ETF, which aligns with the strong performance of the construction materials sector [6]. Group 3 - The top holdings of the leading construction materials fund include companies like Conch Cement and North New Materials, which have shown significant price increases [7]. - The fund's style is categorized as passive index tracking, specifically following the China Securities All Index Construction Materials Index, indicating a focus on the construction materials industry [7]. - In contrast, the pharmaceutical sector funds, such as the Morgan Stanley Hong Kong-Shanghai Select Mixed Fund, have underperformed, with significant declines in key holdings like BeiGene and Zai Lab [7].